Ea Series Trust Prothena Corp Public LTD CO Transaction History
Ea Series Trust
- $2.84 Trillion
- Q2 2023
A detailed history of Ea Series Trust transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Ea Series Trust holds 43,937 shares of PRTA stock, worth $653,782. This represents 0.11% of its overall portfolio holdings.
Number of Shares
43,937Holding current value
$653,782% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
184Shares Held
42.7MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$172 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$62.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$57.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$56.9 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$25.9 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $698M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...